-
KALYDECO in Cystic Fibrosis receives positive CHMP opinion by EMA
- October 21, 2018
- Posted by: Pharmascroll
- Category:
No Comments -
Positive results from new triple combinations in Cystic Fibrosis, displayed by Vertex
- October 21, 2018
- Posted by: Pharmascroll
- Category:
-
Dupixent® (Dupilumab) approved by FDA for Asthma indication
- October 21, 2018
- Posted by: Pharmascroll
- Category:
-
Synspira’s drug receives FDA Orphan Designation for Cystic Fibrosis treatment
- October 16, 2018
- Posted by: Pharmascroll
- Category:
-
Samumed And United Therapeutics enter Agreement For Ph I IPF Drug
- September 17, 2018
- Posted by: Pharmascroll
- Category:
-
Roivant acquires therapy to treat Chronic Cough in IPF patients
- September 6, 2018
- Posted by: Pharmascroll
- Category:
-
Esbriet dose modifications do not alter treatment effect in IPF, study finds
- August 29, 2018
- Posted by: Pharmascroll
- Category:
-
Preclinical Study Results presented for IPF drug BBT-877, by Bridge Biotherapeutics
- August 23, 2018
- Posted by: Pharmascroll
- Category:
-
FDA Approves ORKAMBI in Cystic Fibrosis for Children Ages 2-5 Years
- August 13, 2018
- Posted by: Pharmascroll
- Category:
-
Boehringer Ingelheim to Develop novel Gene Therapy for Cystic Fibrosis
- August 7, 2018
- Posted by: Pharmascroll
- Category: